GO
| HSI1 | 25,930.03 | 0.00 | -- |
| HSCEI1 | 9,174.84 | 0.00 | -- |
| Back Zoom + Zoom - Block Traded | |
|
2025-11-18 12:42:13 UBS released a China market strategy report, listing Buy-rated names with the highest potential FY26 earnings upside for Chinese stocks. The following list only includes Hong Kong-listed and ADR-listed Chinese stocks: Stocks: INNOCARE (09969.HK) CARSGEN-B (02171.HK) ZAI LAB (09688.HK) AKESO (09926.HK) ECARX Holdings (ECX.US) CANSINOBIO (06185.HK) ZHONGSHENG HLDG (00881.HK) BeiGene (ONC.US) Li Auto (LI.US) GDS Holdings (GDS.US) iQiyi (IQ.US) ~ AAStocks Financial News Web Site: www.aastocks.com | |